DUBLIN, Nov. 12, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wm652j/global_biochips) has announced the addition of the "Global Biochips Markets by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering.
The global market for Biochips is expected to grow at an annual growth rate (CAGR) of approximately 18% (2015-2021)
The key players in global biochips market are Agilent technologies Affymetric Inc, Gene system Inc, Agendia BV Inc, Customarray inc, Digital genomics inc, Bio chain institute Inc, Biomerieux SA , Bio-rad laboratories inc, Cepheid Inc, Caliper life sciences Inc, Cybrdi Inc, EMD Millipore, Elim Biopharmaceuticals, Falcon Genomics and Genalyte.
A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of biological analytics and are used in a range of research applications within the biotechnology sector, including pharmaceuticals, proteomics and genomics. Biochips are also used in analysis of organic molecules associated with living organisms and help in identifying gene sequences, airborne toxins, environmental pollutants and other biochemical constituents. Although, biochips have been developed and commercialized in mid eighties but the market has transformed in the starting of last decade.
Presently, the biochips market is undergoing rapid expansion with the discovery of new applications and the development of existing technologies. The key driving forces for the market of biochips are: growth in personalized medicine market, increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as less accuracy of biochips that may lead to wrong analysis, low rate of translation of discoveries in drugs, medical devices and protein biomarkers, low acceptance due to high cost and availability of alternative technologies are restraining the growth of biochips market.
Key Topics Covered:
2. Market overview
3. Market determinants
4. Sector Analysis
5. Market Segmentation
6. Competitive Landscape
7. Geographical analysis
8. Company Profiling
- Affymetrix inc - Agendia BV inc - Agilent technologies - Bio chain institute Inc - Biomerieux SA - Bio-rad laboratories inc - Caliper life sciences inc - Cepheid Inc - Customarray inc - Cybrdi inc - Digital genomics inc - Elim Biopharmaceuticals - EMD Millipore - Falcon Genomics - Fluidigm corp - Gamida for life group - Genalyte - Gene system inc - Illumina Inc - Imgenex - ISU ABXIS co ltd - Life technologies corp - Origene technologies Inc - Oxford gene technology - Perkinelmer inc - Predictive biosciences - Quantalife inc - Roche nimblegen inc - Sequenom - Sigma aldrich corp - Wafergen biosystems inc
For more information visit http://www.researchandmarkets.com/research/wm652j/global_biochips
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets